loading page

Estimation of iron overload with T2*MRI vs. serum ferritin in children treated for hematological malignancies
  • +6
  • Vinay Munikoty,
  • Kushaljit Sodhi,
  • Anmol Bhatia,
  • PRATEEK BHATIA,
  • Savita Attri,
  • ManojKumar Rohit,
  • Amita Trehan,
  • N Khandelwal,
  • Deepak Bansal
Vinay Munikoty
Post Graduate Institute of Medical Education and Research
Author Profile
Kushaljit Sodhi
Post graduate Institute of Medical Education & Research
Author Profile
Anmol Bhatia
Postgraduate Institute of Medical Education and Research
Author Profile
PRATEEK BHATIA
Post Graduate Institute of Medical Education and Research
Author Profile
Savita Attri
Postgraduate Institute of Medical Education and Research
Author Profile
ManojKumar Rohit
Post Graduate Institute of Medical Education and Research, Chandigarh, India
Author Profile
Amita Trehan
postgraduate Institute of Medical Education & Research
Author Profile
N Khandelwal
Postgraduate Institute of Medical Education and Research
Author Profile
Deepak Bansal
Advanced Pediatric Center, Postgraduate Institute of Medical Education and Research

Corresponding Author:[email protected]

Author Profile

Abstract

Background. Iron overload may contribute to complications in childhood cancer survivors. Methodology. Patients treated for hematological malignancy, ≥6 months from the end of therapy, who had received ≥5 red-cell transfusions were enrolled in the cross-sectional study. Iron-overload was estimated by serum ferritin (SF) and T2*MRI. Results. Forty-five survivors were enrolled among 431 treated for hematological malignancies. The median age at diagnosis was 7-years. The median number of red-cell units transfused was 8 (IQR 7, 10). The median duration from the end of treatment was 15 months (IQR 8.75, 25). An elevated SF (>1000 ng/ml), elevated liver iron concentration (LIC) and myocardial iron concentration (MIC) were observed in 5 (11.1%), 20 (45.4%), and 2 (4.5%) patients, respectively. All survivors with SF >1000 ng/ml had elevated LIC. The LIC correlated with SF (p<0.001). MIC lacked correlation with SF or LIC. The number of red-cell units transfused and duration from last transfusion correlated with SF (p=0.001, 0.002) and LIC (p=0.012, 0.005). SF >500 ng/ml predicted elevated LIC with sensitivity/specificity of 80%/79%. A cut-off of 8 units of red-cells predicted elevated LIC with sensitivity/specificity of 95%/49.8%. Conclusions. Iron overload in survivors of hematological malignancies who had received ≥5 red-cell transfusions, estimated by SF, LIC, and MIC was 11.1%, 45.4%, and 4.5%. We suggest screening by SF for survivors who have received >8 transfusions. If SF is 500-1000 ng/ml, a T2*MRI is useful for estimating LIC. A T2*MRI can be avoided if SF exceeds 1000 ng/ml, as LIC will be expected to be elevated.